Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Mulleman

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Metabolomics : Official Journal of the Metabolomic Society|May 24, 2024
A specific diagnostic metabolome signature in adult IgA vasculitisAlexandre Boissais, Hélène Blasco, Patrick Emond, et al.
Clinical and Translational Science|June 19, 2026
European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and PerspectivesKonstantin Tachkov, Merita Rumano, James Bluett, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
British Journal of Clinical Pharmacology|December 21, 2013
Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritisDavid Ternant, Emilie Ducourau, Aleth Perdriger, et al.
The Journal of Rheumatology|March 17, 2006
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significanceEric Toussirot, Edouard Pertuiset, Antoine Martin, et al.
Joint Bone Spine|February 9, 2024
Septic arthritis of the facet joint is also a severe vertebral infection: A multicenter retrospective study of 65 patientsSimon Cadiou, Rachel Tuil, Benoît Le Goff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2015
IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn BindingDavid Ternant, Christophe Arnoult, Martine Pugnière, et al.
RMD Open|August 18, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to considerCharlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Joint Bone Spine|June 17, 2023
Association between radiographic and functional outcome in vertebral osteomyelitis SPONDIMMO, a 6-month prospective multicenter cohortMarie Chevalerias, Guillaume Coiffier, Christelle Darrieutort-Laffite, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Metabolomics : Official Journal of the Metabolomic Society|May 24, 2024
A specific diagnostic metabolome signature in adult IgA vasculitisAlexandre Boissais, Hélène Blasco, Patrick Emond, et al.
Clinical and Translational Science|June 19, 2026
European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and PerspectivesKonstantin Tachkov, Merita Rumano, James Bluett, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
British Journal of Clinical Pharmacology|December 21, 2013
Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritisDavid Ternant, Emilie Ducourau, Aleth Perdriger, et al.
The Journal of Rheumatology|March 17, 2006
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significanceEric Toussirot, Edouard Pertuiset, Antoine Martin, et al.
Joint Bone Spine|February 9, 2024
Septic arthritis of the facet joint is also a severe vertebral infection: A multicenter retrospective study of 65 patientsSimon Cadiou, Rachel Tuil, Benoît Le Goff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2015
IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn BindingDavid Ternant, Christophe Arnoult, Martine Pugnière, et al.
RMD Open|August 18, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to considerCharlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Joint Bone Spine|June 17, 2023
Association between radiographic and functional outcome in vertebral osteomyelitis SPONDIMMO, a 6-month prospective multicenter cohortMarie Chevalerias, Guillaume Coiffier, Christelle Darrieutort-Laffite, et al.
Pageof 10